Trials / Completed
CompletedNCT01172431
Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Old Patients With Mild to Moderate Renal Insufficiency and Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of indapamide SR 1.5 mg on renal function, endothelial function, blood pressure variability by comparison with hydrochlorothiazide 25 mg, in patients with Mild to Moderate Renal Insufficiency and Hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indapamide | Indapamide SR 1.5mg qd |
| DRUG | Hydrochlorothiazide | Hydrochlorothiazide 25mg qd |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-03-01
- Completion
- 2013-12-01
- First posted
- 2010-07-29
- Last updated
- 2014-06-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01172431. Inclusion in this directory is not an endorsement.